The Next Generation, Falling Skies, and Battlestar Galactica are some of the sci-fi shows that get better with every rewatch.

S&P Global announced that four companies will join the S&P 500 index as part of its quarterly rebalance. The additions highlight the rising importance of AI infrastructure within the leading US equity ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and T-cell engagers.

Detailed price information for Mercury Sys Inc (MRCY-Q) from The Globe and Mail including charting and trades.

The cybersecurity implications of the war in the Middle East extend far beyond the region. Here’s where to focus your defenses.

This week，the solid-state battery industry showed a dual-engine momentum driven by "intensive breakthroughs on the technology front and targeted solutions on the policy front." CATL disclosed a ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

Pivotal, Randomized Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) Positions Company at the Forefront of MRD-Guided ...

An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced ...

Introduction Psychedelic-assisted therapy shows promise for treating various mental health conditions; however, its reliance on intensive psychological preparation limits its broader application.

Global commercial drone market to reach 1,755.97 USD Billion by 2035. Analysis of BVLOS, Edge AI, and DaaS models across logistics, energy, and agriculture.

Bicara Therapeutics (NASDAQ:BCAX) is developing tumor-targeting bifunctional antibodies, with its lead candidate ficerasfusp alfa designed to address both EGFR and TGF-beta biology in cancer, company ...